These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 12792506

  • 21. A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation.
    Abu-Elmagd KM, Costa G, Bond GJ, Soltys K, Martin L, Koritsky DA, Cunha-Melo JR, Sogawa H, Irish W, Tzakis A, Mazariegos G.
    Clin Transpl; 2012; ():155-66. PubMed ID: 23721018
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Preliminary experience with Campath 1H induction combined with low-dose monotherapy of tacrolimus in small bowel transplantation].
    Li YX, Li N, Ni XD, Li YS, Li M, Shen J, Li JS.
    Zhonghua Wai Ke Za Zhi; 2009 Jun 01; 47(11):810-3. PubMed ID: 19961008
    [Abstract] [Full Text] [Related]

  • 24. Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation.
    Lauro A, Dazzi A, Ercolani G, Zanfi C, Golfieri L, Amaduzzi A, Cucchetti A, La Barba G, Grazi GL, D'Errico A, Vivarelli M, Cescon M, Varotti G, Del Gaudio M, Ravaioli M, Di Simone M, Faenza S, Pironi L, Pinna AD.
    Transplant Proc; 2007 Jun 01; 39(5):1629-31. PubMed ID: 17580204
    [Abstract] [Full Text] [Related]

  • 25. Single shot of alemtuzumab as induction therapy after kidney transplantation is sufficient.
    Boesmueller C, Sieb M, Pascher A, Klempnauer J, Muehlbacher F, Strasak A, Margreiter R.
    Transpl Int; 2011 Nov 01; 24(11):1053-8. PubMed ID: 21883504
    [Abstract] [Full Text] [Related]

  • 26. Alemtuzumab induction in deceased donor kidney transplantation.
    Shin M, Song SH, Kim JM, Kwon CH, Joh JW, Lee SK, Kim SJ.
    Transplant Proc; 2011 Nov 01; 43(6):2365-78. PubMed ID: 21839271
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
    Pascual J, Pirsch JD, Odorico JS, Torrealba JR, Djamali A, Becker YT, Voss B, Leverson GE, Knechtle SJ, Sollinger HW, Samaniego-Picota MD.
    Transplantation; 2009 Jan 15; 87(1):125-32. PubMed ID: 19136902
    [Abstract] [Full Text] [Related]

  • 30. Intestinal and multivisceral transplantation immunosuppression protocols--literature review.
    Trevizol AP, David AI, Dias ER, Mantovani D, Pécora R, D'Albuquerque LA.
    Transplant Proc; 2012 Oct 15; 44(8):2445-8. PubMed ID: 23026616
    [Abstract] [Full Text] [Related]

  • 31. Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantation.
    Sundberg AK, Roskopf JA, Hartmann EL, Farney AC, Rohr MS, Stratta RJ.
    Transplant Proc; 2005 Mar 15; 37(2):1294-6. PubMed ID: 15848701
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Campath-1H in intestinal and multivisceral transplantation: preliminary data.
    Tzakis AG, Kato T, Nishida S, Levi D, Madariaga J, De Faria W, Nery J, Neff G, Kirk AD, Ruiz P.
    Transplant Proc; 2002 May 15; 34(3):937. PubMed ID: 12034248
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab.
    Kimura T, Lauro A, Cescon M, Zanfi C, Dazzi A, Ercolani G, Grazi GL, Vivarelli M, Ravaioli M, Del Gaudio M, Cucchetti A, Zanello M, LaBarba G, Pironi L, Lazzarotto T, Pinna AD.
    Clin Transplant; 2009 May 15; 23(3):420-5. PubMed ID: 19537304
    [Abstract] [Full Text] [Related]

  • 37. Randomized trial of Alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation.
    Vathsala A, Ona ET, Tan SY, Suresh S, Lou HX, Casasola CB, Wong HC, Machin D, Chiang GS, Danguilan RA, Calne R.
    Transplantation; 2005 Sep 27; 80(6):765-74. PubMed ID: 16210963
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.